ACOR

Acorda Therapeutics, Inc. News Headlines

$30.55
*  
0.67
2.24%
Get ACOR Alerts
*Delayed - data as of Jul. 22, 2014 11:27 ET  -  Find a broker to begin trading ACOR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACOR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Markets Edge Higher; Alcoa Profit Beats Street View
7/9/2014 10:20:52 AM - Benzinga

Actavis Confirms Generic Ampyra Patent Challenge
7/8/2014 5:52:00 PM - RTT News

Sector Update: Healthcare Shares Flat Pre-Market; Acorda Could File Patent Infringement Suit
6/26/2014 8:37:44 AM - MT Newswires

Sector Update: Healthcare
6/26/2014 8:37:06 AM - MT Newswires

ACOR Makes Notable Cross Below Critical Moving Average
6/25/2014 4:32:54 PM - BNK Invest

Acorda Therapeutics (ACOR) in Focus: Stock Moves 7.8% Higher - Tale of the Tape
6/19/2014 9:18:00 AM - Zacks.com

Sector Update: Healthcare
6/18/2014 8:55:02 AM - MT Newswires

Acorda Therapeutics (ACOR) in Focus: Stock Tumbles 9% - Tale of the Tape
6/18/2014 8:55:00 AM - Zacks.com

Sector Update: Healthcare Shares Flat Pre-Market; Pfizer Teams with Cellectis on Immunotherapy
6/18/2014 8:51:02 AM - MT Newswires

Mid-Afternoon Market Update: Oil Falls, US Indexes Rise In Afternoon Session
6/17/2014 3:16:38 PM - Benzinga

Mid-Day Market Update: Amira Rises On Upbeat Earnings; Acorda Therapeutics Shares Tumble
6/17/2014 12:41:01 PM - Benzinga

Mid-Morning Market Update: Markets Gain; FactSet Posts Rise In Revenue
6/17/2014 10:27:12 AM - Benzinga

Acorda Therapeutics To Present At Jefferies Conference; Webcast At 2:30 PM ET
6/2/2014 1:30:00 PM - RTT News

First Week of January 2015 Options Trading For Acorda Therapeutics (ACOR)
5/20/2014 11:59:48 AM - BNK Invest

Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 1:43:01 PM - Zacks.com

Acorda Therapeutics Turns To Profit In Q1 - Quick Facts
5/6/2014 6:29:00 AM - RTT News

Acorda Down on Plumiaz CRL - Analyst Blog
5/5/2014 3:12:01 PM - Zacks.com

ISRG Accelerates Buyback, ECYT Has No Way To PROCEED, ACOR Snubbed By FDA
5/4/2014 11:37:00 PM - RTT News

Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases
4/23/2014 8:48:00 AM - Seeking Alpha

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 1:35:00 PM - Seeking Alpha

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 11:54:36 AM - SeekingAlpha

Next Chapter In The Acorda Story Will Be A Page Turner
4/10/2014 11:54:00 AM - Seeking Alpha

Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha

From Lab Bench To Bedside: David Lowe Brings Common Sense To Neuroscience Investing
3/30/2014 7:38:00 AM - Seeking Alpha

Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape
3/5/2014 10:18:01 AM - Zacks.com